Skip to content
DraconiticResearch
Search Sources API
186,125 studies31 sourcesUpdated 35 min ago
Peer-reviewedCC BY-NC-NDJournal of the American Heart Association

Minimally Invasive Versus Sternotomy in Redo Mitral Valve Surgery: Short‐ and Long‐Term Outcomes with Meta‐Regression and Time‐to‐Event Analysis

5 affiliations
  1. 1New Vision University School of Medicine
  2. 2Universidad Nacional de Asunción
  3. 3Bahçeşehir University
  4. 4Jawaharlal Institute of Postgraduate Medical Education and Research
  5. 5Heart, Thoracic & Vascular Institute; Cleveland Clinic Florida

Abstract

Background Redo mitral valve surgery carries substantial risk, and the relative benefits of minimally invasive (MI‐MVS) versus sternotomy MVS, particularly regarding long‐term survival, remain uncertain. Methods Electronic databases were searched for studies comparing MI‐MVS with sternotomy MVS in adult redo MVS. Kaplan–Meier curves were digitized to reconstruct individual patient data for time‐to‐event analysis, with study‐level hazard ratios (HR) generated using a Cox frailty model. Perioperative outcomes were pooled using random‐effects models. Subgroup analyses evaluated propensity‐matched cohorts, endoscopic/video‐assisted minithoracotomy, and direct‐vision minithoracotomy. Meta‐regression explored the impact of study‐level covariates on mortality. Results Fifteen studies including 3457 patients were analyzed. MI‐MVS was associated with lower perioperative mortality compared with sternotomy MVS (odds ratio [OR], 0.33 [95% CI, 0.23–0.48]; P <0.001), reduced incidence of reoperation (OR, 0.65 [95% CI, 0.44–0.98]; P =0.04), and acute kidney injury (OR, 0.58 [95% CI, 0.39–0.87]; P =0.008); rates of stroke and arrhythmia were similar. The direction and magnitude of the mortality effect consistently favored MI‐MVS in the subgroup analyses. Time‐to‐event analysis demonstrated improved survival with MI‐MVS (HR, 0.74 [95% CI, 0.62–0.89]; P =0.001), but this was attenuated in the propensity‐matched analysis. Meta‐regression showed that sex distribution, mean age, and baseline left ventricular ejection fraction did not significantly moderate mortality effects. Conclusions In redo MVS, MI‐MVS is associated with improved perioperative outcomes without compromising long‐term survival; however, attenuation of the survival difference after propensity matching suggests that this long‐term advantage may reflect baseline risk rather than procedural effect.

Related

  1. Transaxillary minimally invasive mitral valve surgery: early and mid-term outcomes in 763 patients
    Annals of Cardiothoracic SurgeryPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  2. Patient-Reported Outcomes Following Minimally Invasive Versus Conventional Orthognathic Surgery.
    Felix Jose Amarista, Hannah Grimes, Domenic Digioia +1
    Craniomaxillofacial trauma & reconstructionPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. [Comment] Persistent descending mesocolon and its impact on the short-term outcomes of minimally invasive colorectal surgery: a systematic review and meta-analysis
    Wang Xiaojie
    结直肠肛门外科Peer-reviewedCC BY-NC-NDFull textOncologyDOAJ
  4. Impact of previous abdominal surgery on perioperative outcomes after minimally invasive gastrectomy for gastric cancer: an evidence synthesis and quantitative analysis.
    Qi Yue, Yin Huang, Rui-Xi Yu +5
    BMC cancerPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  5. Learning Curve and Early Outcomes of Thoracoscopic Esophageal Atresia Repair in an Emerging Pediatric Minimally Invasive Surgery (MIS) Program: A Cumulative Sum Analysis
    Andreea Moga, Patricia Cîmpeanu, Laura Bălănescu +1
    Children (Basel, Switzerland)Peer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMCDOAJ
BibTeX
@article{santos2026minimally,
  title = {{Minimally Invasive Versus Sternotomy in Redo Mitral Valve Surgery: Short‐ and Long‐Term Outcomes with Meta‐Regression and Time‐to‐Event Analysis}},
  author = {Kristine Santos and Joo Y. B. Kim Kim and Neel Patel and Halima Şah and Sriharsha Koduru and Federico Napoli and Nicolas A. Brozzi and Jose L. Navia and Antonio Polanco and Michel Pompeu Sá},
  journal = {Journal of the American Heart Association},
  year = {2026},
  month = oct,
  doi = {10.1161/jaha.126.050284},
  url = {https://www.ahajournals.org/doi/10.1161/JAHA.126.050284},
  note = {CC BY-NC-ND},
}
RIS
TY  - JOUR
TI  - Minimally Invasive Versus Sternotomy in Redo Mitral Valve Surgery: Short‐ and Long‐Term Outcomes with Meta‐Regression and Time‐to‐Event Analysis
AU  - Kristine Santos
AU  - Joo Y. B. Kim Kim
AU  - Neel Patel
AU  - Halima Şah
AU  - Sriharsha Koduru
AU  - Federico Napoli
AU  - Nicolas A. Brozzi
AU  - Jose L. Navia
AU  - Antonio Polanco
AU  - Michel Pompeu Sá
PY  - 2026
DA  - 2026/10/06
JO  - Journal of the American Heart Association
DO  - 10.1161/jaha.126.050284
UR  - https://www.ahajournals.org/doi/10.1161/JAHA.126.050284
AB  - Background Redo mitral valve surgery carries substantial risk, and the relative benefits of minimally invasive (MI‐MVS) versus sternotomy MVS, particularly regarding long‐term survival, remain uncertain. Methods Electronic databases were searched for studies comparing MI‐MVS with sternotomy MVS in adult redo MVS. Kaplan–Meier curves were digitized to reconstruct individual patient data for time‐to‐event analysis, with study‐level hazard ratios (HR) generated using a Cox frailty model. Perioperative outcomes were pooled using random‐effects models. Subgroup analyses evaluated propensity‐matched cohorts, endoscopic/video‐assisted minithoracotomy, and direct‐vision minithoracotomy. Meta‐regression explored the impact of study‐level covariates on mortality. Results Fifteen studies including 3457 patients were analyzed. MI‐MVS was associated with lower perioperative mortality compared with sternotomy MVS (odds ratio [OR], 0.33 [95% CI, 0.23–0.48]; P <0.001), reduced incidence of reoperation (OR, 0.65 [95% CI, 0.44–0.98]; P =0.04), and acute kidney injury (OR, 0.58 [95% CI, 0.39–0.87]; P =0.008); rates of stroke and arrhythmia were similar. The direction and magnitude of the mortality effect consistently favored MI‐MVS in the subgroup analyses. Time‐to‐event analysis demonstrated improved survival with MI‐MVS (HR, 0.74 [95% CI, 0.62–0.89]; P =0.001), but this was attenuated in the propensity‐matched analysis. Meta‐regression showed that sex distribution, mean age, and baseline left ventricular ejection fraction did not significantly moderate mortality effects. Conclusions In redo MVS, MI‐MVS is associated with improved perioperative outcomes without compromising long‐term survival; however, attenuation of the survival difference after propensity matching suggests that this long‐term advantage may reflect baseline risk rather than procedural effect.
SN  - 2047-9980
ER  -